You are here: Fairness.com > Resources > Pfizer Inc.

Pfizer Inc.


Self Description

July 2002: "The new Pfizer unites the two fastest-growing health care companies. It creates the world's largest and most talented biomedical research organization. It puts the combined power of the industry's best sales, marketing, and manufacturing operations behind a portfolio that includes eight $1 billion prescription medicines and the world's most comprehensive animal health business." http://www.pfizer.com/pfizerinc/about/focus/preeminent_intro.htm

Third-Party Descriptions

May 2010: "Ms. McClain, now 52, says she has suffered bouts of temporary paralysis after being infected by a genetically engineered virus at the Groton lab. A jury last month awarded Ms. McClain $1.37 million, saying Pfizer had fired her for raising questions about laboratory safety."

http://www.nytimes.com/2010/05/28/business/28hazard.html

March 2010: "What Loucks, who was acting U.S. attorney in Boston until November, didn't know until years later was that Pfizer managers were breaking that pledge not to practice off-label marketing even before the ink was dry on their plea."

http://www.washingtonpost.com/wp-dyn/content/article/2010/03/19/AR2010031905578.html

January 2008: 'One major pharmaceutical company, Pfizer, declined to buy drug ingredients from Shanghai Pharmaceutical Group because of quality-related issues, said Christopher Loder, a Pfizer spokesman. In 2006, Pfizer agreed to evaluate Shanghai Pharmaceutical Group’s “capabilities” as an ingredient supplier, but so far the company “has not met the standards required by Pfizer,” Mr. Loder said in a statement.'

http://www.nytimes.com/2008/01/31/world/asia/31pharma.html

January 2008: "Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors."

http://www.nytimes.com/2008/01/14/health/14pain.html

April 2007: In 2005, a federal judge ruled as false and misleading a Listerine mouthwash ad campaign by Pfizer (PFE). The ad claimed that Listerine was as effective as flossing in fighting tooth and gum decay. The judge in that suit ruled that the claim even poses a public health risk.

http://www.businessweek.com/bwdaily/dnflash/content/apr2007/db20070404_698651.htm

January 2007: Twenty-seven members of the pharmaceutical manufacturers organization have endorsed the guidelines, but it is hard to figure exactly how long the delays in advertising will run. Bristol-Myers Squibb has said that it would delay for 12 months. Johnson Johnson & Johnson and Pfizer Johnson and Pfizer said they would wait six months. The manufacturers group cannot say how other companies have interpreted the guidelines, a spokesman said.

http://www.nytimes.com/2007/01/22/business/media/22drug.html

November 2006: But Lilly is hardly alone in benefiting. Pfizer, the world’s largest drug maker, said its sales soared 14 percent in the United States in the third quarter, while rising only 3 percent internationally. Over all, Pfizer said its profits more than doubled, to $3.4 billion from $1.6 billion, though part of the difference came from high one-time charges last year.

http://www.nytimes.com/2006/11/06/business/06drug.html

May 2006: In 1999, 300 pet owners filed a lawsuit against Pfizer Inc., alleging that its early dog arthritis medicine Rimadyl had seriously harmed their pets. Pfizer settled in 2003, saying it had done nothing wrong but wanted to avoid costly litigation. Each plaintiff was given $1,000.

http://www.washingtonpost.com/wp-dyn/content/article/2006/05/11/AR2006051101883.html

May 2006: A panel of Nigerian medical experts has concluded that Pfizer Inc. violated international law during a 1996 epidemic by testing an unapproved drug on children with brain infections at a field hospital.

http://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html

August 2004: Pfizer, the maker of Zoloft, has helped the county solicitor who is prosecuting Christopher Pittman. Plaintiffs' lawyers from Houston and Los Angeles, who between them have brought numerous civil lawsuits against Pfizer and other antidepressant makers, have signed onto the defense team. Groups opposed to pediatric antidepressant use have also championed the boy's case, which is being played out in Chester, S.C., a small town near the North Carolina border.

http://www.nytimes.com/2004/08/23/business/23drug.html

January 2005: ...in 2003 the pharmaceutical industry invested $33.2 billion in drug research. That does not include the nearly $30 billion spent on life sciences by the publicly financed National Institutes of Health, which pays for research that leads to commercial drugs. Weaken the drug industry and you weaken one pillar of the U.S. economy. And Pfizer's trouble with Viagra in China demonstrates just how vulnerable the American knowledge economy is in a world where ideas ''protected'' by our laws trade freely nonetheless.

http://www.nytimes.com/2005/01/09/magazine/09COUNTERFEIT.html

Relationships

RoleNameTypeLast Updated
Status/Name Change from Parke-Davis Organization Jul 29, 2011
Owner of (partial or full, past or present) Pharmacia and Upjohn Organization Mar 23, 2010
Owner of (partial or full, past or present) Warner-Lambert Organization Mar 23, 2010
Employee/Freelancer/Contractor (past or present) David Franklin Person Aug 8, 2004
Financial Supporter of (past or present) Dr. Robert Jarvik M.D. Person Feb 12, 2008
Organization Head/Leader (past or present) Jeffrey B. Kindler Person Apr 27, 2008
Employee/Freelancer/Contractor (past or present) Dr. Eleanor Perfetto Ph.D. Person Apr 8, 2010
Opponent (past or present) Organization Executive (past or present) Dr. Peter Rost M.D. Person Jun 6, 2007
Financial Supporter of (past or present) Noah Wyle Person Jun 19, 2005

Articles and Resources

59 Articles and Resources. Go to:  [Next 20]   [End]

Date Fairness.com Resource Read it at:
Jun 04, 2011 Drug Makers’ Feared Enemy Switches Sides, as Their Lawyer

QUOTE: a year and a half ago, Mr. Loucks, a Republican, left the United States attorney’s office in Boston after he was passed over for the top post and President Obama appointed a Democrat. Instead, Mr. Loucks joined Skadden, Arps last July, and has startled former allies by emerging in recent months as zealous a corporate defender as he was a prosecutor, complete with proposals seeking more lenient treatment for the medical companies he once vilified.

New York Times
May 27, 2010 Safety Rules Can’t Keep Up With Biotech Industry

QUOTE: the estimated 232,000 employees in the nation’s most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory.

New York Times
Mar 21, 2010 When drug makers' profits outweigh penalties

QUOTE: As large as the penalties are for drug companies caught breaking the off-label law, the fines are tiny compared with the firms' annual revenue. The $2.3 billion in fines and penalties Pfizer paid for marketing Bextra and three other drugs cited in the Sept. 2 plea agreement for off-label uses amount to just 14 percent of its $16.8 billion in revenue from selling those medicines from 2001 to 2008.

Bloomberg News
Oct 08, 2009 How to Stop the Counterfeit-Medicine Drugs Trade

QUOTE: According to the World Health Organization (WHO), more than 50% of drugs sold online have either been falsified or altered in some way.

Time Magazine
Oct 02, 2009 Botox Maker’s Suit Cites Free Speech

QUOTE: In an attack on the regulation of drug marketing, the makers of the antiwrinkle shot Botox have filed a free-speech lawsuit against the federal government.

New York Times
Aug 01, 2009 Adaptive Evolution: A once-rare type of clinical trial that violates one of the sacred tenets of trial design is taking off, but is it worth the risk?

QUOTE: in an increasingly common approach, a trial can be altered in various ways while it’s still in progress... Such modifications are based on a peek at interim data—which of necessity means unblinding the data before the trial’s completion.

Scientist, The (TS)
Jul 26, 2009 Lawmakers Seek to Curb Drug Commercials

QUOTE: For some legislators and consumer advocates, the [drug] ads are a daily reminder of a health care system run amok. Critics contend that drug ads are intended to prompt people to diagnose themselves with chronic quality-of-life problems like insomnia or restless leg syndrome; lead people to pressure their doctors for prescriptions for expensive brand-name drugs to treat these conditions; and steer people away from cheaper generic pills.

New York Times
Jul 21, 2009 Industry Cash Flowed To Drafters of Reform: Key Senator Baucus Is a Leading Recipient

QUOTE: Top health executives and lobbyists have continued to flock to the senator's[Max Baucus] often extravagant fundraising events in recent months. During a Senate break in late June, for example, Baucus held his 10th annual fly-fishing and golfing weekend in Big Sky, Mont., for a minimum donation of $2,500.

Washington Post
Jul 06, 2009 Familiar Players in Health Bill Lobbying: Firms Are Enlisting Ex-Lawmakers, Aides

QUOTE: The nation's largest insurers, hospitals and medical groups have hired more than 350 former government staff members and retired members of Congress in hopes of influencing their old bosses and colleagues.... public interest groups and reform advocates complain that the concentration of former government aides on K Street has distorted the health-care debate,

Washington Post
May 15, 2008 Diversity Isn’t Rocket Science, Is It? (Life's Work)

QUOTE: “It’s almost a time warp,” said Sylvia Ann Hewlett, the founder of the Center for Work-Life Policy, a nonprofit organization that studies women and work. “All the predatory and demeaning and discriminatory stuff that went on in workplaces 20, 30 years ago is alive and well in these professions.”

New York Times
Apr 27, 2008 Group Urges Ban on Industry Gifts at Medical Schools

QUOTE: Drug and medical device companies should be banned from offering free food, gifts, travel and ghost-writing services to doctors, staff and students in all 129 of the nation’s medical colleges...The proposed ban is the result of a two-year effort by the Association of American Medical Colleges to create a model policy governing interactions between the schools and industry.

New York Times
Feb 19, 2008 Medication Under a Microscope: Studies Raise Questions About Drugs' Efficacy Against Disease

QUOTE: In addition to casting doubt on notions such as lowering cholesterol to prevent heart disease and normalizing blood sugar to protect diabetics, the studies...have also rekindled concern about whether new medications are being tested adequately before being allowed on the market.

Washington Post
Feb 07, 2008 Drug Ads Raise Questions for Heart Pioneer

QUOTE: ...the Lipitor campaign is a rare instance of a well-known doctor’s endorsing a drug in advertising — and it has helped rekindle a smoldering debate over whether it is appropriate to aim ads for prescription drugs directly at consumers.

New York Times
Jan 31, 2008 Tainted Drugs Linked to Maker of Abortion Pill

QUOTE: A huge state-owned Chinese pharmaceutical company that exports to dozens of countries, including the United States, is at the center of a nationwide drug scandal...Chinese drug regulators have accused the manufacturer of the tainted drugs of a cover-up and have closed the factory that produced them.

New York Times
Jan 17, 2008 Antidepressant Studies Unpublished

QUOTE: The makers of antidepressants like Prozac and Paxil never published the results of about a third of the drug trials that they conducted to win government approval, misleading doctors and consumers about the drugs’ true effectiveness, a new analysis has found.

New York Times
Jan 14, 2008 Drug Approved. Is Disease Real?

QUOTE: For patient advocacy groups and doctors who specialize in fibromyalgia, the Lyrica approval is a milestone. They say they hope Lyrica...will legitimize fibromyalgia, just as Prozac brought depression into the mainstream. But other doctors...say that the disease does not exist and that Lyrica and the other drugs will be taken by millions of people who do not need them.

New York Times
Oct 31, 2007 Chinese Chemicals Flow Unchecked to Market

QUOTE: Because the chemical companies are not required to meet even minimal drug-manufacturing standards, there is little to stop them from exporting unapproved, adulterated or counterfeit ingredients. The substandard formulations made from those ingredients often end up in pharmacies in developing countries and for sale on the Internet, where more Americans are turning for cheap medicine.

New York Times
Jun 06, 2007 A Big Pharma whistleblower blogs on drugs: Booted out of a lucrative career, Peter Rost has become the drug industry's most annoying - and effective - online scourge.

QUOTE: ex-Pfizer senior executive turned blogger believes he has uncovered another instance of unethical marketing by Big Pharma. Today he's taking on AstraZeneca, the British pharmaceutical giant.

Fortune
May 30, 2007 Pfizer Faces Criminal Charges in Nigeria

QUOTE: Officials in Nigeria have brought criminal charges against pharmaceutical giant Pfizer for the company's alleged role in the deaths of children who received an unapproved drug during a meningitis epidemic. .... The move represents a rare -- perhaps unprecedented -- instance in which the developing world's anger at multinational drug companies has boiled over into criminal charges.

Washington Post
Apr 05, 2007 Why the Hype Just Keeps on Coming: Increased scrutiny of advertisers' claims for their products is unlikely to do much to temper their overheated pitches

QUOTE: Why so much product hype? Companies typically face scant public censure when it comes to outrageous product claims. Even if a government agency, plaintiff, or activist cries foul, there's often little penalty to be paid. The few weeks or months that most companies' ad campaigns run are usually over before anyone gets exercised over their claims. By then the companies have already achieved their objective of goosing sales and the public is often unaware of any court rulings or government orders against the ads.

BusinessWeek

59 Articles and Resources. Go to:  [Next 20]   [End]